Braxia Scientific Corp. (BRAXF)
USD 0.0
(21.43%)
USD 0.0
(21.43%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -7.48 Million CAD | -3.79% |
| 2022 | -7.15 Million CAD | 32.89% |
| 2021 | -10.66 Million CAD | -6085.12% |
| 2020 | -172.47 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -789.52 Thousand CAD | 65.51% |
| 2024 Q3 | -857.18 Thousand CAD | -276.31% |
| 2024 Q2 | -259.66 Thousand CAD | 67.11% |
| 2023 Q1 | -948.63 Thousand CAD | 48.97% |
| 2023 FY | -7.43 Million CAD | -3.79% |
| 2023 Q4 | -2.28 Million CAD | 5.41% |
| 2023 Q3 | -2.41 Million CAD | -36.4% |
| 2023 Q2 | -1.77 Million CAD | -87.03% |
| 2022 FY | -7.15 Million CAD | 32.89% |
| 2022 Q2 | -1.71 Million CAD | -59.44% |
| 2022 Q1 | -1.07 Million CAD | 51.45% |
| 2022 Q3 | -2.5 Million CAD | -46.33% |
| 2022 Q4 | -1.85 Million CAD | 25.93% |
| 2021 FY | -10.66 Million CAD | -6085.12% |
| 2021 Q2 | -2.05 Million CAD | 58.63% |
| 2021 Q1 | -4.97 Million CAD | -78.59% |
| 2021 Q3 | -1.57 Million CAD | 23.34% |
| 2021 Q4 | -2.21 Million CAD | -40.55% |
| 2020 Q4 | -2.78 Million CAD | -1756.49% |
| 2020 FY | -172.47 Thousand CAD | 0.0% |
| 2020 Q3 | -149.9 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bioxytran, Inc. | -3.82 Million USD | -95.808% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 89.58% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -2758.002% |
| SQZ Biotechnologies Company | -75.82 Million USD | 90.135% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -162.414% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 58.087% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 109.139% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -386.972% |
| Marizyme, Inc. | -34.08 Million USD | 78.055% |
| Genus plc | 6.4 Million USD | 216.877% |
| Pharming Group N.V. | -4.87 Million USD | -53.296% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -276.552% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -703.124% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 10.418% |
| ContraFect Corporation | -56.88 Million USD | 86.851% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -433.537% |
| IMV Inc. | -38.67 Million USD | 80.657% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -171.922% |
| ONE Bio Corp. | 13.68 Million USD | 154.673% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 87.32% |
| Mesoblast Limited | -84.14 Million USD | 91.111% |
| MultiCell Technologies, Inc. | -722.81 USD | -1034768.776% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 311.303% |
| Genscript Biotech Corporation | -415.79 Million USD | 98.201% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -1820.1% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -184.684% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 252.196% |
| Biomind Labs Inc. | -1 Million USD | -640.899% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -157.825% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -12.517% |
| Skye Bioscience, Inc. | -13.67 Million USD | 45.288% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -301.215% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 176.779% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -24873.741% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -64.228% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -48.283% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 52.865% |
| Accustem Sciences Inc. | -3.74 Million USD | -99.661% |
| EV Biologics, Inc. | -483.06 Thousand USD | -1448.483% |
| Q BioMed Inc. | -3.44 Million USD | -117.091% |
| GB Sciences, Inc. | -1.42 Million USD | -426.581% |
| Alpha Cognition Inc. | -9.7 Million USD | 22.93% |
| CSL Limited | 3.7 Billion USD | 100.202% |
| Agentix Corp. | -1.37 Million USD | -445.296% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 86.393% |
| Enzolytics Inc. | -2.14 Million USD | -248.108% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -12.74 Million USD | 41.328% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -136.095% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -287.048% |
| argenx SE | -425.04 Million USD | 98.24% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 86.524% |
| HST Global, Inc. | -140.9 Thousand USD | -5208.562% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -616.488% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -564.956% |
| Halberd Corporation | -75.05 Thousand USD | -9866.869% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -156.218% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -119.682% |
| Zenith Capital Corp. | -8.94 Million USD | 16.358% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -373.62% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -204.65% |
| AVAX Technologies, Inc. | 6.69 Million USD | 211.763% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -4261.352% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -273.119% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -42837.461% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -2.46 Million USD | -203.237% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -660.135% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -495.552% |
| Kadimastem Ltd | -3.04 Million USD | -146.037% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | 3.842% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -4021.627% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -460.129% |
| LadRx Corporation | -3.82 Million USD | -95.629% |
| Cell Source, Inc. | -4.32 Million USD | -72.937% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1700.364% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -988.891% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -988.891% |
| Affymax, Inc. | -15.04 Million USD | 50.285% |
| Mobile Lads Corp. | -554.55 Thousand USD | -1248.866% |
| Itoco Inc. | -919.14 Thousand USD | -713.819% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -76.484% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -568.466% |
| International Stem Cell Corporation | -663 Thousand USD | -1028.225% |
| CytoDyn Inc. | -18.05 Million USD | 58.577% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -29618.455% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -3298.856% |
| Qrons Inc. | -643.67 Thousand USD | -1062.094% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -1224.567% |
| SYBLEU INC | -149.18 Thousand USD | -4914.167% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -235.45% |
| Rebus Holdings, Inc. | -664 Thousand USD | -1026.526% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -311.829% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -14109.983% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -36675.492% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 79.374% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -362.307% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -916.551% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -140.441% |
| Neutra Corp. | -229.48 Thousand USD | -3159.517% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 57.351% |
| PureTech Health plc | -146.19 Million USD | 94.884% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 65.194% |
| IXICO plc | -1.43 Million USD | -420.538% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 21.187% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 93.859% |
| CSL Limited | 3.81 Billion USD | 100.196% |
| Cellectis S.A. | -108.85 Million USD | 93.128% |